RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Regulatory Harmonization Efforts in India: Keeping in Step With the Globe

Regulatory Harmonization Efforts in India: Keeping in Step With the Globe

Posted 01 June 2008

The Indian pharmaceutical industry has established itself as a key player in the manufacturing arena, with almost half of the active pharmaceutical ingredients (APIs) worldwide being produced there. The double-digit growth rate of the pharmaceutical industry and the economic prosperity brought about by the enormous growth in the high-tech industry in the last 15 years, have transformed India's attractiveness as not only a location for cost-effective pharmaceutical product development but also a key market for finished products. Tremendous new opportunities have been created across all segments of the industry in India from generics to new product research and development (R&D) and contract research and manufacturing services.

 

© 2022 Regulatory Affairs Professionals Society.